Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:6:p13
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 6 (pt 13/36)
Character Range: 344861–347920

medicine labels; or

       (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN;

       (e) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (f) in preparations containing 25% or less of clove oil.
    N‑COCO‑1,3‑DIAMINOPROPANE.
    COCOYL GLYCINATE in cosmetic preparations except:

       (a) in leave‑on preparations containing 5% or less of cocoyl glycinate; or

       (b) in wash‑off preparations containing 30% or less of cocoyl glycinate and, when containing more than 5% of cocoyl glycinate labelled with a warning to the following effect:

           IF IN EYES WASH OUT IMMEDIATELY WITH WATER.
    COPPER ACETATE except:

       (a) when included in Schedule 5; or

       (b) in preparations containing 5% or less of copper acetate.
    COPPER COMPOUNDS except:

       (a) when separately specified in these Schedules; or

       (b) in preparations for human internal use containing 5 mg or less of copper per recommended daily dose; or

       (c) pigments where the solubility of the copper compound(s) in water is 1 g per litre or less; or

       (d) in feed additives containing 1% or less of copper; or

       (e) in other preparations containing 5% or less of copper compounds.
    COPPER HYDROXIDE except:

       (a) when included in Schedule 5; or

       (b) in preparations containing 12.5% or less of copper hydroxide.
    COPPER NITRATE in preparations containing copper chloride for the treatment of footrot in sheep.
    COPPER OXIDES except:

       (a) when included in Schedule 5; or

       (b) in preparations for internal use; or

       (c) in marine paints; or

       (d) in other preparations containing 5% or less of copper oxides.
    COPPER OXYCHLORIDE except:

       (a) when included in Schedule 5; or

       (b) in preparations containing 12.5% of less of copper oxychloride.
    COPPER SULFATE except:

       (a) when included in Schedule 5; or

       (b) in preparations for internal use; or

       (c) in other preparations containing 5% or less of copper sulfate.
    COUMAPHOS:

       (a) in slow‑release plastic matrix ear tags for livestock use containing 6 g or less of coumaphos; or

       (b) in other preparations containing 5% or less of coumaphos.
    COUMATETRALYL in rodenticides containing 1% or less of coumatetralyl except when included in Schedule 5.
    CREOSOTE derived from wood other than beechwood except:

       (a) when included in Schedule 2; or

       (b) in preparations for human therapeutic use containing 10% or less of creosote derived from wood other than